|
|
|
Home >
Health Condition > Alzheimer's Disease
> Exelon
Exelon (rivastigmine tartrate)
Related Topics:
News & Research:
-
Lower Dementia Drug Dose Boosts Brain Function, Cuts Side Effects -
Science Daily, 4/23/09
-
First Alzheimer's patch gets approval - USA Today, 7/9/07
-
Drug
Improves Memory Loss For Traumatic Brain Injury Patients - Science
Daily, 9/18/06
-
Rivastigmine Good Choice For Parkinson's Dementia - Clinical Psychiatry
News, 9/06
-
FDA OKs Drug for Parkinson's Dementia - WebMD, 6/28/06
-
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine
tartrate) as the First Medication Indicated to Treat Parkinson's Disease
Dementia - Doctor's Guide, 6/28/06
-
Treatment of MCI With Rivastigmine: Results From the InDDEx Study -
Doctor's Guide, 4/24/06
-
Trio of Drugs May Improve Alzheimer's - WebMD, 1/25/06
-
Rivastigmine (Exelon) Safe and Effective Alternative for Alzheimer's
Patients Not Responding Adequately to Donepezil (Aricept) - Doctor's
Guide, 5/31/05
-
Rivastigmine Treatment for Alzheimer's Disease Cuts Need for Antipsychotics
- Doctor's Guide, 4/12/05
-
Rivastigmine May Delay Dementia in Parkinson's - Clinical Psychiatry
News, 4/05
- Quetiapine and
Rivastigmine Not Often Helpful for Agitation in Alzheimer's Disease -
Medscape, 2/22/05
-
Exelon (Rivastigmine Tartrate) May Help People With Dementia Associated With
Parkinson's Disease - Doctor's Guide, 12/9/04
- Rivastigmine May Be
Helpful for the Dementia of PD - Medscape, 12/8/04
-
Rivastigmine Benefits Dementia in Parkinson's - Clinical Psychiatry
News, 11/04
-
Rivastigmine May Be More Effective in Patients with More Rapid Alzheimer's
Progression - Doctor's Guide, 10/12/04
-
Rivastigmine May Slow Alzheimer's Progression - Clinical Psychiatry
News, 7/04
-
Rivastigmine Shows Sustained Efficacy in Alzheimer's Patients - Doctor's
Guide, 6/21/04
-
Rivastigmine May Slow Progression of Moderately Severe Alzheimer's Disease
- Doctor's Guide, 4/15/04
- Alzheimer's
Drug [Exelon] May Slow Down Disease - WebMD, 2/25/04
-
Drug Interactions with Cholinesterase Inhibitors: a Review - Doctor's
Guide, 10/23/03
-
Rivastigmine Switch Well Tolerated - Clinical Psychiatry News, 10/03
-
Exelon (Rivastigmine Tartrate) Reduces Behavioral Disturbances Associated
With Alzheimer's Disease - Doctor's Guide, 8/22/03
- Drug May Slow
Alzheimer's Progression - WebMD, 6/18/03
-
Exelon (Rivastigmine) May Slow Progression Of Alzheimer Disease -
Doctor's Guide, 6/18/03
-
Start Cholinesterase Inhibitor Immediately After Alzheimer's Dx -
Clinical Psychiatry News, 6/03
-
Antipsychotics Effective for Elderly Patients With Dementia -
Psychiatric News, 4/18/03 -
"atypical
antipsychotics have been used to alleviate deteriorating behavioral
symptoms in dementia patients, such as agitation and aggression. New
research that she cited shows some atypical antipsychotics can actually
improve cognition through activating the release of acetylcholine in the
cortex. Clozapine,
olanzapine, and risperidone,
she reported, robustly increased acetylcholine release in the cortex, while
ziprasidone only moderately increased
levels, compared with haloperidol
and thioridazine, which did not elevate acetylcholine levels at all ...
atypical antipsychotics increase cortical dopamine and
cholinesterase inhibitors at the very least increase cortical
acetylcholine action, leading to an improvement in memory and thinking, as
well as improvement in psychosis and behavior"
-
Alzheimer’s Drugs May Offer Psychiatric Benefits - psychiatryonline.org,
2/7/02
-
Drug Update: Alzheimer's Disease - Clinical Psychiatry News, 2/03
- Alzheimer's
Drugs Help More Than Memory - WebMD, 1/7/03 -
"Four such drugs have been approved by the FDA for
use in the U.S. -- Reminyl, approved
in 2001; Exelon, approved in 2000;
Aricept, approved in 1996; and Cognex, approved in 1993, but rarely used
now because it can cause liver problems ... treatment with one of these
drugs for at least one month slowed the worsening of functional skills such
as the ability to dress, bathe and shop. And it improved psychiatric
symptoms including depression,
hallucinations, delusions,
anxiety, and apathy"
-
Rivastigmine Improves Cholinergic Activity in Alzheimer's Disease -
Doctor's Guide, 11/29/02
- Rivastigmine May Be
Helpful in Subcortical Vascular Dementia - Medscape, 11/22/02
-
Rivastigmine, Donepezil Produce Sustained Benefit in Alzheimer's Patients
- Doctor's Guide, 10/14/02
- In a Newly Published
Study, More Alzheimer's Disease Patients Were Able to Benefit from ARICEPT®
(donepezil) Treatment than Exelon® (rivastigmine) - Doctor's Guide,
8/6/02
- In A Newly Published Study
More Alzheimer's Disease Patients Were Able To Benefit From Aricept
(Donepezil HCl Tablets) Treatment Than Exelon (Rivastigmine Tartrate) -
Doctor's Guide, 7/31/02
-
Rivastigmine-Risperidone Co-administration Safe in Dementia Patients with
Behavioural Disturbances - Doctor's Guide, 7/23/02
-
Rivastigmine, Donepezil Combination Well Tolerated and Efficacious -
Doctor's Guide, 7/22/02
-
Cognitive Decline Rapid and not Regained Following Discontinuation of
Acetylecholinesterase Inhibitors - Doctor's Guide, 7/22/02
-
Rivastigmine Appears to Ease Parkinsonian Hallucinations - Clinical
Psychiatry News, 6/02
-
Switch from Donepezil to Rivastigmine Well Tolerated in Elderly Patients
with Alzheimer's Disease - Doctor's Guide, 5/15/02
-
Alzheimer's Patients Who Fail On Aricept (Donepezil) May Benefit From Exelon
(Rivastigmine) - Doctor's Guide, 5/2/02
-
Acetylcholinesterase Inhibitors Improve Behavior - Clinical Psychiatry
News, 4/02
- Up and Coming
Drugs for Parkinson's - WebMD, 4/18/02
-
Exelon (Rivastigmine) Shows Long-term Efficacy in Alzheimer's disease -
Doctor's Guide, 4/5/02
-
Exelon (Rivastigmine) Improves Activities of Daily Living Over Course of
Alzheimer's Disease - Doctor's Guide, 2/26/02
- Exelon (Rivastigmine)
Beneficial In Subcortical Vascular Dementia - Doctor's Guide, 1/28/02
- Rivastigmine Tartrate May
Reduce Cognitive Deficits in Patients with Schizophrenia - Doctor's
Guide, 11/20/01
- Rivastigmine Provides
Behavioral And Cognitive Benefits In Nursing Home Patients With Alzheimer’s
- Doctor's Guide, 10/3/01
- Donepezil Preferred To
Rivastigmine For Physician Convenience In Alzheimer's Treatment -
Doctor's Guide, 6/18/01
- Donepezil and Rivastigmine
May Be Combined In Alzheimer's Patients - Doctor's Guide, 5/12/01
- Donepezil Better Tolerated
Than Rivastigmine, Efficacy Comparable - Doctor's Guide, 5/11/01 -
"both drugs to provide effective cognitive
improvement in patients with Alzheimer’s dementia, but donepezil to have
fewer cholinergic side effects"
- Rapid Switching From
Aricept (Donepezil) to Exelon (Rivastigmine) Well Tolerated in Alzheimer's
- Doctor's Guide, 5/11/01
- Donepezil Better Tolerated
Than Rivastigmine In Alzheimer’s Patients - Doctor's Guide, 2/26/01
- Exelon (Rivastigmine
Tartrate) Delays Progression Of Mild To Moderately Severe Alzheimer's
Disease - Doctor's Guide, 11/13/00
- Aricept (Donepezil HCl)
Better Tolerated Than Exelon (Rivastigmine Tartrate) In Mild And Moderate
Alzheimer’s - Doctor's Guide, 9/27/00
- Exelon (Rivastigmine
Tartrate) Now Available In US For Alzheimer's Disease - Doctor's Guide,
6/21/00
- FDA Grants Marketing
Clearance For Alzheimer’s Drug Exelon (Rivastigmine Tartrate) - Doctor's
Guide, 4/24/00
- Different Measurements
Used To Show Efficacy Of Alzheimer's Treatments - Doctor's Guide,
4/10/00
- Rivastigmine Helps
Maintain Daily Functioning In Alzheimer’s Patients - Doctor's Guide,
10/15/99
- Exelon Effective For Mild
To Moderate Alzheimer's - Doctor's Guide, 3/5/99
Abstracts:
Related Searches:
70519
|
|
